U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07709416) titled 'Toludesvenlafaxine for Non-specific Low Back Pain' on July 12.
Brief Summary: Chronic non-specific low back pain is the leading cause of productivity loss and disability worldwide, constituting a major public health challenge. This study aims to systematically evaluate and compare the role of the antidepressant drug toludesvenlafaxine in chronic non-specific low back pain, which is of critical importance for optimising clinical practice and developing precise, individualised treatment regimens.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Non-specific Low Back Pain
Intervention:
DRUG: Active Comparator #1
...